Drug Profile of FDA-Approved New Drug: Avacopan

Abstract

Avacopan is one of the FDA (Food and Drug Administration) approved drugs that is used for the treatment of vasculitis. Vasculitis is a disease that is distinguished by inflammation and destruction of a small blood vessel. Avacopan has received approval in September 2021 in Japan for (MPA) microscopic polyangiitis. This article aimed to provide a review, qualitative and quantitative analysis of the physicochemical, pharmaceutical, and pharmacological properties of the drug. This literature result provide in detail information on avacopan with the help of various aspects. Contraindications, directions for the use of the drug, and pharmacokinetic and pharmacodynamics properties of the drug are studied in this review article. From this review, we conclude different pharmacological, pharmaceutical, and physicochemical aspects of avacopan.